Hermetica Superfood Encyclopedia
The Short Answer
Platycodin D is a triterpenoid saponin isolated from Platycodon grandiflorum (balloon flower root) that exerts anti-cancer and anti-inflammatory effects primarily by inducing caspase-mediated apoptosis and suppressing PI3K/Akt signaling. Research also demonstrates anti-angiogenic activity through inhibition of VEGF-driven endothelial cell proliferation and tube formation.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary KeywordPlatycodin D benefits
Synergy Pairings5
Platycodin D — botanical close-up
Health Benefits
Origin & History
Natural habitat
Platycodin D is a triterpenoid saponin extracted from the roots of Platycodon grandiflorum (balloon flower), a plant native to East Asia. It appears as a white crystalline powder with a molecular formula of C57H92O28, typically extracted through preparative HPLC, column chromatography, or solvent fractionation methods.
“While Platycodin D itself lacks direct historical documentation, it derives from Platycodon grandiflorum roots, used in Traditional Chinese Medicine and Korean medicine for over 2,000 years. The plant appears in ancient texts like the Shennong Bencao Jing for treating respiratory issues, cough, phlegm, and lung conditions.”Traditional Medicine
Scientific Research
No human clinical trials, RCTs, or meta-analyses for Platycodin D were identified in the available sources. All evidence is limited to preclinical in vitro and animal studies, with no PMIDs provided for human trials.
Preparation & Dosage
Traditional preparation
No clinically studied dosage ranges in humans are available. Preclinical studies used concentrations of 0.2-1.2 mg/mL for antioxidant assays and 0.3-10 μM for anti-angiogenic effects in cell models. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Platycodin D is a purified triterpenoid saponin compound (not a whole food), therefore it does not possess a conventional macronutrient or micronutrient profile. Key characterization data: Molecular formula C57H92O28, molecular weight 1225.34 g/mol. It is the primary bioactive saponin isolated from Platycodon grandiflorum (balloon flower root), typically constituting approximately 0.1–0.5% dry weight of the crude root extract. As an isolated compound, it contains no meaningful protein, fat, carbohydrate, fiber, vitamins, or minerals in its purified form. Bioactive compound classification: bidesmosidic triterpenoid saponin with an oleanolic acid aglycone core linked to two sugar chains. Bioavailability is notably limited due to its high molecular weight and glycosidic structure; oral bioavailability is low, with intestinal bacteria partially hydrolyzing it to monodesmosidic saponins (e.g., platycodin D3) which may exhibit enhanced membrane permeability. Studies indicate plasma concentrations following oral dosing in rodent models reach nanomolar to low micromolar ranges. Amphiphilic structure (hydrophilic sugar chains + hydrophobic aglycone) allows membrane interaction, relevant to its biological activity. No dietary reference intake or recommended daily value exists, as it is a pharmacologically studied phytochemical rather than a nutritional substance. Studied concentrations in vitro range from 0.3–50 μM depending on the biological endpoint.
How It Works
Mechanism of Action
Platycodin D induces apoptosis by activating caspase-3 and caspase-9 while downregulating the PI3K/Akt survival pathway, reducing phosphorylated Akt expression in gastric and colorectal cancer cell lines. It suppresses angiogenesis by inhibiting VEGF receptor signaling, reducing HUVEC tube formation and cell motility at concentrations of 0.3–10 μM. Additionally, it modulates NF-κB transcriptional activity, dampening downstream pro-inflammatory cytokine production including TNF-α and IL-6.
Clinical Evidence
Evidence for Platycodin D currently derives entirely from in vitro cell studies and in vivo mouse xenograft models, with no completed human clinical trials published as of 2024. In vitro studies demonstrated cytotoxicity against human gastric cancer (SGC-7901) and colorectal cancer (HCT-15) cell lines, with measurable apoptosis induction at low micromolar concentrations. HCT-15 xenograft mouse studies showed statistically significant tumor growth suppression compared to vehicle controls, though dosing and bioavailability differ substantially from human oral exposure. The overall evidence base is preliminary, and efficacy in human populations remains unestablished.
Safety & Interactions
Platycodin D and its parent plant extract (Platycodon grandiflorum) are generally considered low-toxicity at culinary doses, but high-dose saponin preparations may cause gastrointestinal irritation including nausea and diarrhea. Due to its Akt-suppressing activity, theoretical interactions with PI3K inhibitor drugs (e.g., idelalisib, alpelisib) or immunosuppressants are plausible but unconfirmed in human studies. Platycodon root extracts have historically been avoided in pregnancy in traditional medicine contexts due to insufficient safety data, and this caution extends to isolated Platycodin D. No formal drug interaction studies exist, so concurrent use with anticoagulants or chemotherapy agents should be approached with caution and medical supervision.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
What is Platycodin D and where does it come from?
Platycodin D is a bidesmosidic triterpenoid saponin extracted from the dried root of Platycodon grandiflorum, commonly called balloon flower or Chinese bellflower. It is one of the primary bioactive compounds responsible for the root's documented pharmacological effects, including anti-inflammatory and anti-tumor activities studied in laboratory settings.
Does Platycodin D kill cancer cells?
Platycodin D has demonstrated the ability to kill human cancer cells in vitro by activating the intrinsic apoptosis pathway, specifically through caspase-3 and caspase-9 activation and downregulation of phosphorylated Akt in gastric and colorectal cancer cell lines. Mouse xenograft models using HCT-15 cells also showed tumor suppression, but no human clinical trials have been conducted, so these findings cannot be translated into cancer treatment claims.
What dose of Platycodin D was used in research studies?
In vitro anti-angiogenic studies employed concentrations of 0.3–10 μM to inhibit HUVEC tube formation and endothelial cell motility, while cytotoxicity experiments in cancer cell lines typically used concentrations in the 1–50 μM range. Human-equivalent dosing has not been established because no pharmacokinetic or clinical dose-ranging studies in humans have been published.
Is Platycodin D safe to take as a supplement?
Isolated Platycodin D is not widely available as a standardized supplement, and formal human safety trials are lacking. Platycodon grandiflorum root extracts have a long history of use in traditional East Asian medicine with a reasonable safety profile at culinary doses, but concentrated saponin fractions may irritate the gastrointestinal tract. Pregnant or breastfeeding individuals and those on prescription medications, particularly cancer therapies or immunosuppressants, should consult a physician before use.
How does Platycodin D differ from other saponins like ginsenosides?
Platycodin D is a triterpenoid saponin from the oleanane-type structural class found in Platycodon grandiflorum, whereas ginsenosides are dammarane-type triterpenoid saponins derived from Panax ginseng with distinct glycosidic attachments and receptor targets. While both classes share general properties such as surfactant activity and immune modulation, Platycodin D's documented anti-angiogenic mechanism via VEGF pathway inhibition and Akt suppression represents a partially distinct pharmacological profile compared to the adaptogenic and neuroprotective mechanisms more commonly attributed to ginsenosides.
What is the current quality of clinical evidence for Platycodin D's health benefits?
Most evidence for Platycodin D comes from in vitro (cell culture) and animal studies, with limited human clinical trials currently available. While promising results have been observed in laboratory settings for anti-cancer and anti-angiogenic properties, these preliminary findings have not been consistently confirmed in human populations. More rigorous clinical research is needed before strong health claims can be made about Platycodin D supplementation.
Can I obtain meaningful amounts of Platycodin D from food sources?
Platycodin D is naturally present in Platycodon grandiflorum (Chinese bellflower) root, which is used in traditional Asian medicine and cuisine, particularly in Korea where it's known as doraji. However, the concentration of Platycodin D in food preparations is typically much lower than doses used in research studies, making dietary sources alone unlikely to achieve the concentrations tested in scientific investigations. Supplemental extracts are generally required to reach the 0.3-10 μM concentrations studied in laboratory research.
Who should be cautious about using Platycodin D supplements?
Individuals with bleeding disorders, those taking anticoagulant or antiplatelet medications, and pregnant or nursing women should exercise caution, as saponin-based compounds like Platycodin D may have mild blood-thinning properties and safety data in these populations is limited. People with gastrointestinal sensitivity may experience irritation from saponins, and those with known allergies to plants in the Campanulaceae family should avoid Platycodon-derived supplements. Consultation with a healthcare provider is recommended before use, particularly for individuals on medications or with existing health conditions.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w platycodin-d curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
